Zenichi Morise, MD, PhD, FACS, is a professor of surgery in Fujita Health University School of Medicine (Japan) and the founding director of Fujita Health University Okazaki Medical Center. He was received his medical degree and PhD from Keio University (Japan). He is also Program officer of Japan Agency for Medical Research and Development, Founding member and Committee member (education) of International Laparoscopic Liver Society, Committee member (education) of International Society of Digestive Surgery, Editor in Chief of Gastroenterology research (Elmer press), Deputy Chief Editor of Fujita Medical Journal (Official journal of Fujita Health University). He had been working on hepato-pancreato-biliary, mainly liver, diseases and surgeries. Currently, his main research interest is minimally invasive liver surgery, especially for Hepatocellular carcinoma. He published the world-first paper describing the novel concept of “Caudal approach” in laparoscopic liver surgery in 2013, which was defined as a main conceptual change in minimally invasive liver surgery in the 2nd international consensus conference of laparoscopic liver resection in 2014. The concept has been followed by many papers including his own works. He had been doing research and publication about the advantages of minimally invasive liver surgery, such as for patients with impaired liver function and repeat liver resection from the very early era of laparoscopic liver resection. Including those topics, he conducted several ILLS (International laparoscopic liver society)-related projects and published the papers. He has been continuously working and publishing on international collaboration studies for minimally invasive liver surgery. He also recently published the world-first paper about minimally invasive liver resection using novel Japanese robot surgical system "hinotori". He has published more than 180 articles in peer-reviewed journals such as World Journal of Gastroenterology, New England Journal of Medicine, Gastroenterology, Journal of Hepatology, Annals of Surgery, British Journal of Surgery, Cancers and many others. His current h-index is over 30. In the role of founding director of Fujita Health University Okazaki Medical Center, he prepared the university hospital from scratch and run until it became well-functioning and profitable, beside he conducted the project of accommodating and caring 128 COVID positive patients from the cruise ship in Yokohama at the facility, which was finished successfully with no death nor no extra infected person just before the openings (Feb-Mar 2020) both of the hospital and the pandemic in Japan.